Maureen Cox, PhD, and Jumana Abbadi, MD, explain how macrophage-derived BDNF drives sensory nerve growth into triple-negative breast tumors, a potential drug target.
Jumana Abbadi, MD
Advertisement
Articles by Jumana Abbadi, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Iberdomide, the First CELMoD for Relapsed/Refractory Multiple Myeloma
2
ASTRO Issues Updated Clinical Practice Guideline on RT for Pancreatic Cancer
3
FAQ: When and How to Discontinue Lenalidomide Maintenance in Multiple Myeloma
4
With 4 Guideline-Preferred Options, CNS Activity Is Deciding Frontline ROS1+ NSCLC Therapy
5